Dubuque Bank & Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $244K | Hold |
3,257
| – | – | 0.03% | 195 |
|
|
2023
Q2 | $251K | Buy |
3,257
+450
| +16% | +$35.9K | 0.03% | 189 |
|
|
2023
Q1 | $233K | Hold |
2,807
| – | – | 0.03% | 191 |
|
|
2022
Q4 | $241K | Buy |
+2,807
| New | +$222K | 0.03% | 186 |
|
|
2022
Q3 | – | Sell |
-3,329
| Closed | -$206K | – | 223 |
|
|
2022
Q2 | $206K | Buy |
+3,329
| New | +$206K | 0.03% | 198 |
|
|
2022
Q1 | – | Sell |
-3,351
| Closed | -$243K | – | 255 |
|
|
2021
Q4 | $243K | Sell |
3,351
-75
| -2% | -$5.17K | 0.03% | 217 |
|
|
2021
Q3 | $239K | Buy |
3,426
+62
| +2% | +$4.36K | 0.03% | 234 |
|
|
2021
Q2 | $232K | Sell |
3,364
-1,734
| -34% | -$116K | 0.03% | 237 |
|
|
2021
Q1 | $329K | Sell |
5,098
-24
| -0.5% | -$1.55K | 0.04% | 197 |
|
|
2020
Q4 | $298K | Buy |
5,122
+414
| +9% | +$25K | 0.04% | 199 |
|
|
2020
Q3 | $298K | Hold |
4,708
| – | – | 0.04% | 167 |
|
|
2020
Q2 | $362K | Sell |
4,708
-164
| -3% | -$12.6K | 0.06% | 153 |
|
|
2020
Q1 | $365K | Buy |
+4,872
| New | +$337K | 0.07% | 147 |
|
|
2019
Q2 | – | Sell |
-1,396
| Closed | -$91K | – | 343 |
|
|
2019
Q1 | $91K | Hold |
1,396
| – | – | 0.01% | 220 |
|
|
2018
Q4 | $87K | Hold |
1,396
| – | – | 0.02% | 208 |
|
|
2018
Q3 | $108K | Sell |
1,396
-15
| -1% | -$1.13K | 0.02% | 199 |
|
|
2018
Q2 | $100K | Sell |
1,411
-36
| -2% | -$2.54K | 0.02% | 250 |
|
|
2018
Q1 | $109K | Sell |
1,447
-22
| -1% | -$1.75K | 0.02% | 278 |
|
|
2017
Q4 | $105K | Sell |
1,469
-352
| -19% | -$26.7K | 0.02% | 277 |
|
|
2017
Q3 | $148K | Buy |
1,821
+1,114
| +158% | +$85.2K | 0.02% | 250 |
|
|
2017
Q2 | $50K | Sell |
707
-935
| -57% | -$62.2K | 0.01% | 320 |
|
|
2017
Q1 | $112K | Buy |
1,642
+267
| +19% | +$18.8K | 0.02% | 254 |
|
|
2016
Q4 | $98K | Sell |
1,375
-59,323
| -98% | -$4.41M | 0.02% | 188 |
|
|
2016
Q3 | $4.8M | Buy |
60,698
+3,733
| +7% | +$303K | 0.9% | 32 |
|
|
2016
Q2 | $4.75M | Buy |
56,965
+3,689
| +7% | +$327K | 0.92% | 26 |
|
|
2016
Q1 | $4.89M | Buy |
53,276
+14,980
| +39% | +$1.35M | 0.94% | 25 |
|
|
2015
Q4 | $3.88M | Buy |
38,296
+1,441
| +4% | +$150K | 0.82% | 30 |
|
|
2015
Q3 | $3.62M | Sell |
36,855
-389
| -1% | -$43.2K | 0.78% | 27 |
|
|
2015
Q2 | $4.36M | Sell |
37,244
-1,793
| -5% | -$196K | 0.81% | 26 |
|
|
2015
Q1 | $3.83M | Sell |
39,037
-1,325
| -3% | -$135K | 0.57% | 37 |
|
|
2014
Q4 | $3.81M | Sell |
40,362
-8,627
| -18% | -$892K | 0.61% | 43 |
|
|
2014
Q3 | $5.21M | Sell |
48,989
-2,980
| -6% | -$292K | 0.86% | 37 |
|
|
2014
Q2 | $4.31M | Buy |
51,969
+1,840
| +4% | +$143K | 0.68% | 47 |
|
|
2014
Q1 | $3.55M | Buy |
50,129
+49,275
| +5,770% | +$3.86M | 0.64% | 47 |
|
|
2013
Q4 | $64K | Hold |
854
| – | – | 0.01% | 205 |
|
|
2013
Q3 | $54K | Buy |
+854
| New | +$51K | 0.01% | 212 |
|
Other funds holding GILD
Dubuque Bank & Trust's GILD Position: Q3 2023 in Review
Dubuque Bank & Trust held its Gilead Sciences (GILD) position steady in Q3 2023 at 3,257 shares worth $244K. The position accounts for 0.03% of the portfolio, ranked #195.
Dubuque Bank & Trust first reported a position in GILD in Q3 2013 and has held it in 36 quarters since. The position peaked at $5.21M in Q3 2014. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.
- Dubuque Bank & Trust held 3,257 shares of Gilead Sciences worth $244K as of Q3 2023.
- Dubuque Bank & Trust left its Gilead Sciences share count unchanged in Q3 2023.
- Gilead Sciences made up 0.03% of Dubuque Bank & Trust's portfolio in Q3 2023, its #195 holding.
- Dubuque Bank & Trust first reported a position in Gilead Sciences in Q3 2013 and has held it in 36 quarters since.
- Dubuque Bank & Trust's Gilead Sciences position peaked at $5.21M in Q3 2014.
- 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.
Based on Dubuque Bank & Trust's 13F filing for Q3 2023, filed 27 Oct 2023.